BRYCE MANTON: Open Payments
NPI 1326721523 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$927 in 44 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $1,277 · 2025 $927
Food & beverage: $927
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 12 | $218 |
| ABBVIE INC. | 8 | $197 |
| Novo Nordisk Inc | 6 | $114 |
| AstraZeneca Pharmaceuticals LP | 4 | $80 |
| Lilly USA, LLC | 4 | $75 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $60 |
| Sumitomo Pharma America, Inc. | 2 | $53 |
| Globus Medical, Inc. | 1 | $44 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $29 |
| Abbott Laboratories | 1 | $25 |
Products named: NURTEC ODT, QULIPTA, UBRELVY, MOUNJARO, Wegovy, JARDIANCE, GEMTESA, Ozempic.
Industry payments across NC — which companies pay providers there.
